Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: A retrospective cohort study

BMJ Open

Volumn 8, Issue 7, 2018, Pages

  Li, Yu Hsuan ^a   Sheu, Wayne H H ^a,b   Lee, I Te ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

diabetes endocrinology; diabetic nephropathy and vascular disease; diabetic retinopathy

Indexed keywords

ALBUMIN; GLUCOSE; PROTEIN;

ADULT; ALBUMINURIA; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE REGISTRY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MORTALITY RATE; MORTALITY RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN; URINARY EXCRETION; AGED; CASE CONTROL STUDY; DIABETIC NEPHROPATHY; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; PUBLIC HOSPITAL; REGISTER;

ADULT; AGED; ALBUMINURIA; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HOSPITALS, VETERANS; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 85051183878     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2018-021655     Document Type: Article

References (55)

1. Collins AJ, Foley RN, Chavers B, et al. United States renal data system 2011 annual data report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012;59:A7, e1-420.
2. Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology 2010;15(Suppl 2):3-9.
3. Crawford TN, Alfaro DV, Kerrison JB, et al. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009;5:8-13.
4. Maffi P, Secchi A. The burden of diabetes: Emerging data. Dev Ophthalmol 2017;60:1-5.
5. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179-83.
6. Porrini E, Ruggenenti P, Mogensen CE, et al. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endocrinol 2015;3:382-91.
7. American Diabetes Association. 10. Microvascular complications and foot care. Diabetes Care 2017;40:S88-S98.
8. Lee IT, Sheu WH, Lin SY. The impact of creatinine clearance rate, daily urinary albumin, and their joint effect on predicting death in diabetic inpatients after discharge: An observational study. Medicine 2016;95:e2804.
9. Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316:602-10.
10. Kramer HJ, Nguyen QD, Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-7.
11. Pugliese G. Updating the natural history of diabetic nephropathy. Acta Diabetol 2014;51:905-15.
12. Willard AL, Herman IM. Vascular complications and diabetes: Current therapies and future challenges. J Ophthalmol 2012;2012:1-14.
13. Eshaq RS, Aldalati AMZ, Alexander JS, et al. Diabetic retinopathy: Breaking the barrier. Pathophysiology 2017;24:229-41.
14. Cheung N, Wang JJ, Klein R, et al. Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study. Diabetes Care 2007;30:1742-6.
15. Xie J, Ikram MK, Cotch MF, et al. Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: A systematic review and meta-analysis. JAMA Ophthalmol 2017;135:586-93.
16. Alonso N, Traveset A, Rubinat E, et al. Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol 2015;14:33.
17. Ellis TP, Choudhury RH, Kaul K, et al. Diabetic retinopathy and atherosclerosis: Is there a link? Curr Diabetes Rev 2013;9:146-60.
18. Kramer CK, Rodrigues TC, Canani LH, et al. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: Meta-analysis of observational studies. Diabetes Care 2011;34:1238-44.
19. Hsieh YM, Lee WJ, Sheu WH, et al. Inpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients: A retrospective cohort study. Diabetol Metab Syndr 2017;9:29.
20. Torffvit O, Lövestam-Adrian M, Agardh E, et al. Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: A 12-year observation study of 462 patients. Diabet Med 2005;22:723-9.
21. van Hecke MV, Dekker JM, Stehouwer CD, et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: The EURODIAB prospective complications study. Diabetes Care 2005;28:1383-9.
22. Parving HH, Mogensen CE, Thomas MC, et al. Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: Insights from the RENAAL study. QJM 2005;98:119-26.
23. Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet 2017;389:1238-52.
24. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014;63:713-35.
25. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1):S14-80.
26. Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
27. Bruno G, Merletti F, Bargero G, et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: The Casale Monferrato study. Diabetologia 2007;50:941-8.
28. So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006;29:2046-52.
29. Wada T, Haneda M, Furuichi K, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 2014;18:613-20.
30. Pálsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis 2014;21:273-80.
31. Toyama T, Furuichi K, Ninomiya T, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: Meta-analysis. PLoS One 2013;8:e71810.
32. Svensson MK, Cederholm J, Eliasson B, et al. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register. Diab Vasc Dis Res 2013;10:520-9.
33. Rigalleau V, Lasseur C, Raffaitin C, et al. Normoalbuminuric renalinsufficient diabetic patients: A lower-risk group. Diabetes Care 2007;30:2034-9.
34. Lee E, Oh HJ, Park JT, et al. The incidence of cardiovascular events is comparable between normoalbuminuric and albuminuric diabetic patients with chronic kidney disease. Medicine 2016;95:e3175.
35. Hsieh YT, Kuo JF, Su SL, et al. Subnormal estimated glomerular filtration rate strongly predict incident cardiovascular events in type 2 diabetic Chinese population with normoalbuminuria. Medicine 2016;95:e2200.
36. Katayama S, Moriya T, Tanaka S, et al. Low transition rate from normo-A nd low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: The Japan Diabetes Complications Study (JDCS). Diabetologia 2011;54:1025-31.
37. Ekinci EI, Jerums G, Skene A, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care 2013;36:3620-6.
38. Shimizu M, Furuichi K, Yokoyama H, et al. Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol 2014;18:305-12.
39. Thomas MC, Macisaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009;32:1497-502.
40. Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011;29:1802-9.
41. Yokoyama H, Sone H, Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: The Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009;24:1212-9.
42. Pugliese G, Solini A, Bonora E, et al. Chronic kidney disease in type 2 diabetes: Lessons from the renal insufficiency and cardiovascular events (RIACE) Italian Multicentre Study. Nutr Metab Cardiovasc Dis 2014;24:815-22.
43. Tanamas SK, Saulnier PJ, Fufaa GD, et al. Long-term effect of losartan on kidney disease in American Indians with type 2 diabetes: A follow-up analysis of a randomized clinical trial. Diabetes Care 2016;39:2004-10.
44. Penno G, Solini A, Zoppini G, et al. Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care 2012;35:2317-23.
45. Rodríguez-Poncelas A, Mundet-Tudurí X, Miravet-Jiménez S, et al. Chronic kidney disease and diabetic retinopathy in patients with type 2 diabetes. PLoS One 2016;11:e0149448.
46. Ricardo AC, Grunwald JE, Parvathaneni S, et al. Retinopathy and CKD as predictors of all-cause and cardiovascular mortality: National Health and Nutrition Examination Survey (NHANES) 1988-1994. Am J Kidney Dis 2014;64:198-203.
47. Grunwald JE, Pistilli M, Ying GS, et al. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study). Am J Cardiol 2015;116:1527-33.
48. Semeraro F, Cancarini A, dell'Omo R, et al. Diabetic retinopathy: Vascular and inflammatory disease. J Diabetes Res 2015;2015:1-16.
49. Chang HW, Li YH, Hsieh CH, et al. Association of body mass index with all-cause mortality in patients with diabetes: A systemic review and meta-analysis. Cardiovasc Diagn Ther 2016;6:109-19.
50. Cea Soriano L, Johansson S, Stefansson B, et al. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: Associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol 2015;14:38.
51. Pugliese G, Solini A, Fondelli C, et al. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study. Nephrol Dial Transplant 2011;26:3950-4.
52. Karoli R, Fatima J, Shukla V, et al. Predictors of diabetic retinopathy in patients with type 2 diabetes who have normoalbuminuria. Ann Med Health Sci Res 2013;3:536-40.
53. Yoon HE, Kim ES, Mo EY, et al. High normal albuminuria is associated with arterial stiffness and carotid atherosclerosis in Korean patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2015;25:787-94.
54. Salinero-Fort MÁ, San Andrés-Rebollo FJ, de Burgos-Lunar C, et al. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES cohort study: Association with chronic kidney disease. J Diabetes Complications 2016;30:227-36.
55. Chen LI, Guh JY, Wu KD, et al. Modification of diet in renal disease (MDRD) study and CKD epidemiology collaboration (CKD-EPI) equations for Taiwanese adults. PLoS One 2014;9:e99645.